This insight brief analyzes how tariffs and trade policies are affecting the U.S. medical technology sector, including manufacturing costs, supply chains, pricing strategies, and market competitiveness. It outlines direct and indirect impacts such as increased input costs, sourcing disruptions, and pressure on margins. The brief also explores how companies are responding through supply chain diversification, pricing adjustments, and regulatory planning. IQVIA emphasizes the importance of data-driven scenario modeling and proactive strategy to help MedTech organizations mitigate risk, maintain access to innovation, and navigate ongoing global trade uncertainty.

Join for free to read